Securian Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Securian Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-9,082	Closed	-$1.57M	–	998
2015 Q1	$1.57M	Buy	9,082 +187	+2%	+$27.5K	0.05%	357
2014 Q4	$1.02M	Sell	8,895 -100	-1%	-$12.1K	0.03%	466
2014 Q3	$1.41M	Buy	8,995 +110	+1%	+$15.9K	0.05%	349
2014 Q2	$1.1M	Sell	8,885 -254	-3%	-$28.1K	0.04%	425
2014 Q1	$947K	Hold	9,139	–	–	0.03%	453
2013 Q4	$822K	Sell	9,139 -44	-0.5%	-$3.51K	0.03%	510
2013 Q3	$614K	Buy	+9,183	New	+$633K	0.02%	609

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Securian Asset Management's SLXP Position: Q2 2015 in Review

Securian Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 9,082 shares — an estimated $1.57M sold.

Securian Asset Management first reported a position in SLXP in Q3 2013 and held it in 7 quarters. The position peaked at $1.57M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Securian Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Securian Asset Management sold 9,082 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.57M.
Securian Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 7 quarters.
Securian Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.57M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Securian Asset Management's 13F filing for Q2 2015, filed 10 Aug 2015.